Physician profile
Gregory Daniel Judy
NPI 1366881807
$969.02
in general payments reported to CMS, 2019-2025
16 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $29.85 · 2021: $255 · 2022: $177 · 2023: $166 · 2024: $36.74 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $280.79 | 2019-2025 | Optune, Optune Lua (Novottf-200t) |
| Astellas Pharma US INC | $141.89 | 2021-2023 | Xtandi |
| Siemens Medical Solutions USA, INC. | $117.47 | 2025 | Varian Ethos Treatment Planning, Eclipse Treatment Planning System For External Beam Radiation Therapy, Aria Radiation Therapy Management Software |
| Progenics Pharmaceuticals, INC. | $92.41 | 2021-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $58.99 | 2019-2022 | |
| Isoray, INC | $54.71 | 2022-2023 | Brachytherapy Source |
| Blue Earth Diagnostics | $50.79 | 2022-2023 | |
| Boston Scientific Corporation | $28.48 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $24.56 | 2019 | |
| Pfizer INC. | $21.09 | 2022 | |
| Endo Pharmaceuticals INC. | $19.17 | 2022 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Varian Medical Systems, INC. | $16.25 | 2020 | |
| Merck Sharp & Dohme LLC | $15.61 | 2021 | |
| Rochester Medical Corporation | $14.78 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Judy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.